Home Cart Sign in  
Chemical Structure| 31430-15-6 Chemical Structure| 31430-15-6

Structure of Flubendazole
CAS No.: 31430-15-6

Chemical Structure| 31430-15-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Flubendazole is a potent broad spectrum anthelmintic.

Synonyms: NSC 313680; Flumoxanal; R-17899

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Flubendazole

CAS No. :31430-15-6
Formula : C16H12FN3O3
M.W : 313.28
SMILES Code : O=C(OC)NC1=NC2=CC(C(C3=CC=C(F)C=C3)=O)=CC=C2N1
Synonyms :
NSC 313680; Flumoxanal; R-17899
MDL No. :MFCD00871999
InChI Key :CPEUVMUXAHMANV-UHFFFAOYSA-N
Pubchem ID :35802

Safety of Flubendazole

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
T-98G 0.5 µM 24 hours Inhibited cell proliferation and promoted cell apoptosis Cell Death Discov. 2018 Feb 14;4:18.
SF-268 0.4 µM 24 hours Inhibited cell proliferation and promoted cell apoptosis Cell Death Discov. 2018 Feb 14;4:18.
MDA-MB-468 0.5 µM 24 hours Evaluate the inhibitory effect of Flubendazole on TNBC cell proliferation, results showed Flubendazole significantly inhibited cell proliferation. Theranostics. 2020 Jul 2;10(18):8080-8097.
MDA-MB-231 0.5 µM 24 hours Evaluate the inhibitory effect of Flubendazole on TNBC cell proliferation, results showed Flubendazole significantly inhibited cell proliferation. Theranostics. 2020 Jul 2;10(18):8080-8097.
MCF-7 cells 1.5 µM 24 hours Evaluate the inhibitory effect of flubendazole and paclitaxel on cell proliferation, and found that flubendazole enhanced the inhibitory effect of paclitaxel on MCF-7 cell proliferation Int J Mol Sci. 2023 Oct 12;24(20):15121.
MDA-MB-231 cells 1.5 µM 24 hours Evaluate the inhibitory effect of flubendazole and paclitaxel on cell proliferation, and found that flubendazole enhanced the inhibitory effect of paclitaxel on MDA-MB-231 cell proliferation Int J Mol Sci. 2023 Oct 12;24(20):15121.
PC-9 0.5, 1, 2 µM 24 hours To evaluate the effect of Flubendazole on autophagy in PC-9 cells. Results showed that Flubendazole significantly increased LC3-II expression, indicating autophagy activation. Front Cell Dev Biol. 2021 Aug 26;9:680600.
A549 0.5, 1, 2 µM 24 hours To evaluate the effect of Flubendazole on autophagy in A549 cells. Results showed that Flubendazole significantly increased LC3-II expression, indicating autophagy activation. Front Cell Dev Biol. 2021 Aug 26;9:680600.
Adult female Brugia malayi 100 nM to 10 µM 24 to 120 hours To evaluate the tissue damage effects of FLBZ on adult female Brugia malayi. Results showed that FLBZ caused significant damage to the hypodermis and developing embryos at concentrations as low as 100 nM after 24 hours of exposure. Int J Parasitol Drugs Drug Resist. 2015 Jul 7;5(3):135-40.
H460 0.5, 1, 2 µM 36 hours To evaluate the effect of Flubendazole on apoptosis in H460 cells. Results showed that Flubendazole significantly induced apoptosis in H460 cells in a dose-dependent manner. Front Cell Dev Biol. 2021 Aug 26;9:680600.
SW480 0-400 µM 48 hours Evaluate the inhibitory effect of Flubendazole on CRC cell proliferation, results showed Flubendazole significantly inhibited SW480 cell proliferation with IC50 of 2-5μM J Exp Clin Cancer Res. 2019 Jul 8;38(1):293.
RKO 0-400 µM 48 hours Evaluate the inhibitory effect of Flubendazole on CRC cell proliferation, results showed Flubendazole significantly inhibited RKO cell proliferation with IC50 of 2-5μM J Exp Clin Cancer Res. 2019 Jul 8;38(1):293.
HCT116 0-400 µM 48 hours Evaluate the inhibitory effect of Flubendazole on CRC cell proliferation, results showed Flubendazole significantly inhibited HCT116 cell proliferation with IC50 of 2-5μM J Exp Clin Cancer Res. 2019 Jul 8;38(1):293.
SNU449 0.25, 0.50, 1.00 µM 72 hours Flubendazole inhibits HCC cell proliferation in a dose-dependent manner. Int J Biol Sci. 2023 Apr 23;19(7):2270-2288.
MHCC-97H 0.25, 0.50, 1.00 µM 72 hours Flubendazole inhibits HCC cell proliferation in a dose-dependent manner. Int J Biol Sci. 2023 Apr 23;19(7):2270-2288.
Huh7 0.25, 0.50, 1.00 µM 72 hours Flubendazole inhibits HCC cell proliferation in a dose-dependent manner. Int J Biol Sci. 2023 Apr 23;19(7):2270-2288.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c nude mice NSCLC xenograft model Intraperitoneal injection 10 and 20 mg/kg Every other day for 14 days To evaluate the antitumor effect of Flubendazole in the NSCLC xenograft model. Results showed that Flubendazole significantly inhibited tumor growth without causing significant physiological toxicity. Front Cell Dev Biol. 2021 Aug 26;9:680600.
BALB/c nude mice HCT116 xenograft model Intraperitoneal injection 10 mg/kg or 30 mg/kg Every other day for 14 days Evaluate the antitumor effect of Flubendazole in vivo, results showed Flubendazole significantly inhibited tumor growth J Exp Clin Cancer Res. 2019 Jul 8;38(1):293.
Nude mice Xenograft tumor model Subcutaneous injection 10, 20, 40 mg/kg Once daily until the end of the study Evaluate the inhibitory effect of Flubendazole on TNBC tumor growth in vivo, results showed Flubendazole significantly inhibited tumor growth. Theranostics. 2020 Jul 2;10(18):8080-8097.
Mice Cryptococcal meningitis model Oral 2, 4, 6, 8, 12 mg/kg Once daily for 10 days To evaluate the pharmacodynamics of Flubendazole in a murine model of cryptococcal meningitis, showing significant reduction in fungal burden at the highest dose (12 mg/kg/day). Antimicrob Agents Chemother. 2018 Mar 27;62(4):e01909-17
Nude mice Xenograft tumor model Intraperitoneal injection 25 mg/kg Once daily for 25 days Inhibited tumor growth Cell Death Discov. 2018 Feb 14;4:18.
BALB/c nude mice Subcutaneous xenograft model Peritoneal injection 40 mg/kg Three times per week until tumor volume reached approximately 2000 mm3 Flubendazole significantly inhibits HCC tumor growth, with tumor volumes and weights significantly lower than the control group. Int J Biol Sci. 2023 Apr 23;19(7):2270-2288.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.19mL

0.64mL

0.32mL

15.96mL

3.19mL

1.60mL

31.92mL

6.38mL

3.19mL

References

 

Historical Records

Categories